Trinity Biotech reported $78.25M in Current Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Bayer BAYN:GR 31.94B 506M
Bio Rad Laboratories BIO:US $ 2466.29M 177.19M
Cytori Therapeutics CYTX:US $ 22.1M 4.1M
Edap Tms EDAP:US $ 64.67M 0.7M
Mesa Laboratories MLAB:US $ 319.4M 4.09M
Orasure Technologies OSUR:US $ 289.23M 4.18M
Oxford Immunotec Global OXFD:US $ 188.37M 1.42M
Siemens SIE:GR 52.34B 328M
Sientra SIEN:US 146.78M 4.76M
Surmodics SRDX:US $ 70.26M 23.86M
Thermo Fisher Scientific TMO:US $ 24724M 5464M
Tosoh 4042:JP 581.65B 25.64B
Trinity Biotech TRIB:US $ 78.25M 3.22M
Veracyte VCYT:US $ 229.31M 142.04M